TY - JOUR
T1 - RAB3GAP2 is a regulator of skeletal muscle endothelial cell proliferation and associated with capillary-to-fiber ratio
AU - Ström, Kristoffer
AU - Oskolkov, Nikolay
AU - Karaderi, Tugce
AU - Kalamajski, Sebastian
AU - Mir, Bilal A.
AU - Ekström, Ola
AU - Miyamoto-Mikami, Eri
AU - Ladenvall, Claes
AU - Kakulidis, Ellen
AU - Reid, Steven
AU - Dutius Andersson, Anna Maria
AU - Kryvokhyzha, Dmytro
AU - Zhang, Enming
AU - Fadista, Joao
AU - Thangam, Manonanthini
AU - Iemitsu, Motoyuki
AU - Semenova, Ekaterina A.
AU - Larin, Andrey K.
AU - Sultanov, Rinat I.
AU - Babalyan, Konstantin A.
AU - Zhelankin, Andrey V.
AU - Kulemin, Nikolay A.
AU - Generozov, Edward V.
AU - Hultström, Michael
AU - Frithiof, Robert
AU - Zeberg, Hugo
AU - Lipcsey, Miklos
AU - Larsson, Anders
AU - Mahajan, Anubha
AU - Ahlqvist, Emma
AU - Prasad, Rashmi B.
AU - Prüfer, Kay
AU - Sabater-Lleal, Maria
AU - Smith, Nicholas L.
AU - Dehghan, Abbas
AU - Lind, Lars
AU - McGawley, Kerry
AU - Morris, Andrew P.
AU - Andersson, Johan P.A.
AU - Lehtovirta, Mikko
AU - Szczerbiński, Łukasz
AU - Kretowski, Adam
AU - Ahmetov, Ildus I.
AU - Wang, Guan
AU - Pitsiladis, Yannis
AU - Santos-Lozano, Alejandro
AU - Lucia, Alejandro
AU - Fuku, Noriyuki
AU - Holmberg, Hans Christer
AU - Gomez, Maria F.
AU - Eriksson, Karl Fredrik
AU - Pietras, Kristian
AU - Lindgren, Cecilia M.
AU - Franks, Paul W.
AU - Hansson, Ola
AU - CHARGE Hemostasis Working Group
N1 - This study was supported by the Swedish Research Council through Strategic Research Area EXODIAB (Dnr 2009-1039), project grants (Dnr 2018-02635, 2018-02837, 2018-03086, and 2020-02191), and a Linnaeus grant (Dnr 349-2006-237); Swedish Foundation for Strategic Research (Dnr IRC15-0067); Swedish Heart-Lung Foundation (Dnr 20190470 and 20220606); Crafoord Foundation; Wallenberg Foundation; Novo Nordisk Foundation (Dnr. NNF21OC0070457); Magn. Bergvall Foundation: Påhlsson Foundation; Diabetes Wellness; Swedish Diabetes Research Foundation; Hjelt Foundation; European Research Council (CoG-2015_681742_NASCENT); and Region Skåne. N.O. is financially supported by the Knut and Alice Wallenberg Foundation as part of the National Bioinformatics Infrastructure Sweden at SciLifeLab. T.K. is supported by a Novo Nordisk Foundation Data Science Investigator grant (NNF20OC0062294). P.W.F. and S.K. were supported by grants from the Novo Nordisk Foundation, Swedish Research Council (#2019-01348), and European Commission (ERC-CoG_NASCENT-681742). M.S.-L. is supported by a Miguel Servet contract from the ISCIII Spanish Health Institute (CPII22/00007) and cofinanced by the European Social Fund. The Pronmed was funded by the SciLifeLab/Knut and Alice Wallenberg National COVID-19 research program (M.H.; KAW 2020.0182 and KAW 2020.0241), the Swedish Heart-Lung Foundation (M.H.; 20210089, 20190639, and 20190637), the Swedish Research Council (R.F.; 2014-02569 and 2014-07606), the Swedish Society of Medicine (M.H.; SLS-938101), and the Swedish Kidney Foundation (R.F.; F2020-0054). The gene expression study in athletes was supported by a grant from the Russian Science Foundation (24-15-00413). Support for the FUSION Tissue Biopsy Study dataset (dbGaP accession phs001048.v2.p1) was contributed by the NHGRI intramural projects ZIAHG000024 and Z1BHG000196; NIDDK grants DK062370, DK072193, and DK099240; NHGRI grant HG003079; American Diabetes Association Pathway to Stop Diabetes Grant 1-14-INI-07; and grants from the Academy of Finland. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Publisher Copyright:
© 2026 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license. http://creativecommons.org/licenses/by/4.0/
PY - 2026/2/24
Y1 - 2026/2/24
N2 - Skeletal muscle capillary density is correlated with physical performance and whole-body metabolic properties. Thus, we performed a genome-wide association study of skeletal muscle capillary-to-fiber ratio (C:F) (n = 603 males) and found that the rs115660502 G allele was associated (p < 5 × 10−8) with increased C:F and reduced skeletal muscle expression of RAB3 GTPase-activating non-catalytic protein subunit 2 (RAB3GAP2). The capillary-increasing G allele was more prevalent in elite endurance athletes than in power athletes and non-athlete controls in two independent cohorts. Low-muscle-expressing RAB3GAP2 expression quantitative trait locus (eQTL) alleles were associated with muscle damage in athletes. In healthy individuals, RAB3GAP2 expression was reduced by high-intensity intermittent training. RAB3GAP2 protein was not uniformly expressed in muscle but predominantly expressed in the endothelium and capillaries. RAB3GAP2 expression was lower in endurance compared with power athletes and was negatively associated with type I (oxidative) muscle fiber density. Experimental reduction of RAB3GAP2 in human endothelial cells led to (1) increased proliferation and tube formation in vitro, (2) regulation of secreted factors (e.g., CD70 and TNC) promoting angiogenesis and T cell activation, and (3) increased in vivo endothelial cell density in mice. RAB3GAP2 expression in skeletal muscle was negatively correlated with exercise-induced release of TNC in vivo in humans. In conclusion, RAB3GAP2 is expressed in the microvascular endothelium and is suggested to be a negative regulator of angiogenesis through a decrease in endothelial cell proliferation, possibly mediated by RAB18, with its low-expressing variant associated with higher muscle C:F and elite endurance performance.
AB - Skeletal muscle capillary density is correlated with physical performance and whole-body metabolic properties. Thus, we performed a genome-wide association study of skeletal muscle capillary-to-fiber ratio (C:F) (n = 603 males) and found that the rs115660502 G allele was associated (p < 5 × 10−8) with increased C:F and reduced skeletal muscle expression of RAB3 GTPase-activating non-catalytic protein subunit 2 (RAB3GAP2). The capillary-increasing G allele was more prevalent in elite endurance athletes than in power athletes and non-athlete controls in two independent cohorts. Low-muscle-expressing RAB3GAP2 expression quantitative trait locus (eQTL) alleles were associated with muscle damage in athletes. In healthy individuals, RAB3GAP2 expression was reduced by high-intensity intermittent training. RAB3GAP2 protein was not uniformly expressed in muscle but predominantly expressed in the endothelium and capillaries. RAB3GAP2 expression was lower in endurance compared with power athletes and was negatively associated with type I (oxidative) muscle fiber density. Experimental reduction of RAB3GAP2 in human endothelial cells led to (1) increased proliferation and tube formation in vitro, (2) regulation of secreted factors (e.g., CD70 and TNC) promoting angiogenesis and T cell activation, and (3) increased in vivo endothelial cell density in mice. RAB3GAP2 expression in skeletal muscle was negatively correlated with exercise-induced release of TNC in vivo in humans. In conclusion, RAB3GAP2 is expressed in the microvascular endothelium and is suggested to be a negative regulator of angiogenesis through a decrease in endothelial cell proliferation, possibly mediated by RAB18, with its low-expressing variant associated with higher muscle C:F and elite endurance performance.
KW - angiogenesis
KW - capillary density
KW - elite athletes
KW - exercise
KW - genetics
KW - microvascular endothelium
KW - RAB18
KW - RAB3 GTPase-activating non-catalytic protein subunit 2
KW - RAB3GAP2
KW - skeletal muscle
UR - https://www.scopus.com/pages/publications/105031631246
UR - https://www.sciencedirect.com/science/article/pii/S2211124726000392?via%3Dihub
U2 - 10.1016/j.celrep.2026.116961
DO - 10.1016/j.celrep.2026.116961
M3 - Journal article
C2 - 41678332
AN - SCOPUS:105031631246
SN - 2639-1856
VL - 45
JO - Cell Reports
JF - Cell Reports
IS - 2
M1 - 116961
ER -